Literature DB >> 27012389

Medical Management of Meningiomas: Current Status, Failed Treatments, and Promising Horizons.

Michael Karsy1, Jian Guan1, Adam Cohen2, Howard Colman3, Randy L Jensen4.   

Abstract

Meningiomas are benign tumors of the central nervous system, with low recurrence risk for World Health Organization (WHO) grade I lesions but a high risk for WHO grade II and III lesions. Current standard treatments include maximum safe surgical resection when indicated and radiation. Only three systemic therapies alpha-interferon, somatostatin receptor agonists, and vascular endothelial growth factor inhibitors are currently recommended by the National Comprehensive Cancer Network for treatment of recurrent meningioma. This paper aims to review medical approaches in the treatment of meningiomas.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetics; Medical management; Meningiomas; Targeted treatment

Mesh：

Substances：

Year:  2016        PMID： 27012389     DOI： 10.1016/j.nec.2015.11.002

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN： 1042-3680            Impact factor:   2.509


  17 in total

1.  Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.

Authors:  Christine G Skibinski; Tara Williamson; Gregory J Riggins
Journal:  J Neurooncol       Date:  2018-11-09       Impact factor: 4.130

2.  Primary and Secondary Optic Nerve Sheath Meningioma.

Authors:  Elena Solli; Roger E Turbin
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

Review 3.  An overview of meningiomas.

Authors:  Robin A Buerki; Craig M Horbinski; Timothy Kruser; Peleg M Horowitz; Charles David James; Rimas V Lukas
Journal:  Future Oncol       Date:  2018-08-07       Impact factor: 3.404

4.  Clinical Outcomes of Recurrent Intracranial Meningiomas Treated with Proton Beam Reirradiation.

Authors:  Brandon S Imber; Brian Neal; Dana L Casey; Heba Darwish; Andrew L Lin; Oren Cahlon; Brian Chon; Henry Tsai; Eugen Hug; Yoshiya Yamada; T Jonathan Yang
Journal:  Int J Part Ther       Date:  2019-05-01

Review 5.  Accuracy of Raman spectroscopy in differentiating brain tumor from normal brain tissue.

Authors:  Jing Zhang; Yimeng Fan; Min He; Xuelei Ma; Yanlin Song; Ming Liu; Jianguo Xu
Journal:  Oncotarget       Date:  2017-05-30

6.  Genetic variants and increased risk of meningioma: an updated meta-analysis.

Authors:  Xiao-Yong Han; Wei Wang; Lei-Lei Wang; Xi-Rui Wang; Gang Li
Journal:  Onco Targets Ther       Date:  2017-03-28       Impact factor: 4.147

7.  A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas.

Authors:  Maya Hrachova; Emely Nhi T Nguyen; Beverly D Fu; Manisha J Dandekar; Xiao-Tang Kong; Gilbert Cadena; Frank P K Hsu; John Billimek; Thomas H Taylor; Daniela A Bota
Journal:  Front Neurol       Date:  2020-05-06       Impact factor: 4.003

8.  Stimulated Raman Histology for Intraoperative Guidance in the Resection of a Recurrent Atypical Spheno-orbital Meningioma: A Case Report and Review of Literature.

Authors:  Evan Luther; Alejandro Matus; Daniel G Eichberg; Ashish H Shah; Michael Ivan
Journal:  Cureus       Date:  2019-10-14

Review 9.  Recent advances in managing/understanding meningioma.

Authors:  Nawal Shaikh; Karan Dixit; Jeffrey Raizer
Journal:  F1000Res       Date:  2018-04-24

10.  Protein Kinase A Distribution in Meningioma.

Authors:  Antonio Caretta; Luca Denaro; Domenico D'Avella; Carla Mucignat-Caretta
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.